Comparison of Standard Versus Low Bicarbonate Hemodialysis
Primary Purpose
Chronic Kidney Disease, Metabolic Acidosis
Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Low bicarbonate dialysis
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Kidney Disease focused on measuring bicarbonate, dialysis
Eligibility Criteria
Inclusion Criteria:
- Receiving chronic thrice-weekly conventional hemodialysis for at least 3 months
- Age > 18 years
Exclusion Criteria:
- Use of oral alkali within the previous month
- Hospitalization within the previous month
- Inability to provide written informed consent
- Pregnancy
Sites / Locations
- Montefiore Medical Center/Jack D. Weiler Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Low bicarbonate dialysis
Arm Description
Outcomes
Primary Outcome Measures
Change in beta-hydroxybutyrate clearance
Comparison between 2 hemodialysis treatments with different bicarbonate dialysis concentrations
Change in lactate clearance
Comparison between 2 hemodialysis treatments with different bicarbonate dialysis concentrations
Post-dialysis pH
Post-dialysis bicarbonate
Secondary Outcome Measures
Full Information
NCT ID
NCT01777178
First Posted
January 24, 2013
Last Updated
April 26, 2019
Sponsor
Albert Einstein College of Medicine
1. Study Identification
Unique Protocol Identification Number
NCT01777178
Brief Title
Comparison of Standard Versus Low Bicarbonate Hemodialysis
Official Title
Intradialytic Acid-base Changes and Organic Anion Production With Standard Versus Low Bicarbonate Hemodialysis
Study Type
Interventional
2. Study Status
Record Verification Date
June 2013
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
June 2013 (Actual)
Study Completion Date
June 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Albert Einstein College of Medicine
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will compare acid-base changes during hemodialysis treatments with a standard dialysis bath versus a lower bicarbonate dialysis bath, and aims to define the factors that limit equilibration of the bicarbonate concentration in a patient's blood with that in the dialysate.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Disease, Metabolic Acidosis
Keywords
bicarbonate, dialysis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Low bicarbonate dialysis
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Low bicarbonate dialysis
Primary Outcome Measure Information:
Title
Change in beta-hydroxybutyrate clearance
Description
Comparison between 2 hemodialysis treatments with different bicarbonate dialysis concentrations
Time Frame
1-2 weeks
Title
Change in lactate clearance
Description
Comparison between 2 hemodialysis treatments with different bicarbonate dialysis concentrations
Time Frame
1-2 weeks
Title
Post-dialysis pH
Time Frame
1-2 weeks
Title
Post-dialysis bicarbonate
Time Frame
1-2 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Receiving chronic thrice-weekly conventional hemodialysis for at least 3 months
Age > 18 years
Exclusion Criteria:
Use of oral alkali within the previous month
Hospitalization within the previous month
Inability to provide written informed consent
Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matthew K Abramowitz, MD, MS
Organizational Affiliation
Albert Einstein College of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Montefiore Medical Center/Jack D. Weiler Hospital
City
Bronx
State/Province
New York
ZIP/Postal Code
10461
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Comparison of Standard Versus Low Bicarbonate Hemodialysis
We'll reach out to this number within 24 hrs